Abstract:
A panel (3) having an inlet (12) for a disc cartridge (13) is attached to the front side of a mechanism body (2) consisting of a chassis, a magnetic head, etc., and the mechanism body (2) is elastically attached to the inner sides of upper and lower cases (6) and (7) through the intermediation of a plurality of buffer rubber members (11). The upper and lower cases (6) and (7) are integrally joined together to form a casing (1), and a buffer member (5) is attached to an opening (4) formed on the front side of the casing (1). This buffer member (5) has a rectangular frame-like through-hole (17) at its center, and holding members (5a) and (5b) formed around it are inserted into holding grooves (7c) formed in the cases (6) and (7). Further, a frame member (5c) is formed on the back side of the buffer member (5) so as to surround the through-hole (17), and the panel (3) is inserted into the frame member (5c) and exposed through the opening (4).
Abstract:
A method of manufacturing a modified wood material, wherein a raw wood material is processed in a first bath of a first solution containing metallic ions high in the affinity and showing insoluble and non-flammable properties within the wood material, and then in a second bath of a second solution containing negative ions which produces an insoluble, non-flammable inorganic composition upon reaction with the metallic ions, whereby the obtained modified wood material is made to have the insoluble, non-flammable inorganic composition produced and fixed therein to allow the material to hold a good flame retardancy and excellent rotproof and mothproof properties.
Abstract:
Modulators of CRTH2, particularly antagonists of CRTH2, that are useful for treating various disorders, including asthma and respiratory disorders are disclosed herein. The compounds are described by structural Formula I:
Abstract:
The present disclosure relates to compounds useful as agonists of cannabinoid receptors. The disclosure also provides pharmaceutically acceptable compositions comprising the compounds of the disclosure and methods of using the compositions in the treatment of various disorders either alone or in combination therapy. The compounds have Formula (I), or are pharmaceutically acceptable salts thereof:
Abstract:
The present disclosure relates to compounds of formula I useful as agonists of cannabinoid receptors. The disclosure also provides pharmaceutically acceptable compositions comprising the compounds of the disclosure and methods of using the compositions in the treatment of various disorders.
Abstract:
A Process for production of 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or salts thereof which comprises using as a starting compound as a (phenylthio)acetic acid derivative or salts thereof represented by the general formula: wherein X1 represents a halogen atom, is useful as a safe process for mass production of 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or salts thereof which is useful as a remedy for disease of central and peripheral nerve.
Abstract:
The present invention provides a hydrophobic group-introduced hyaluronic acid derivative comprising at least one repeating unit represented by the formula (I): wherein R1, R2, R3, R4, Z, n, Ra, Y, and X1 are as defined in the specification.